Joseph Newman is a structural biologist working in the Centre for Medicines Discovery at the University of Oxford where he uses structural biology to identify and develop novel starting points for drug development against targets involved in DNA repair pathways. His role at READDI-AC is to provide structural and mechanistic insights, X-ray fragment screening data and structural support for medicinal chemistry optimisation of inhibitors targeting viral helicases.
